Aptamer Sciences Inc
KOSDAQ:291650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
KR |
|
L
|
Lion One Metals Ltd
OTC:LOMLF
|
CA |
|
Kornit Digital Ltd
NASDAQ:KRNT
|
IL |
|
Petrotal Corp
XTSX:TAL
|
US |
|
S
|
Showa Shinku Co Ltd
TSE:6384
|
JP |
|
EPIC Corp
OTC:EPOR
|
US |
|
I
|
Ironwood Pharmaceuticals Inc
F:I76
|
US |
|
Shadowfax Technologies Ltd
NSE:SHADOWFAX
|
IN |
|
A
|
ARoot Co Ltd
KOSDAQ:096690
|
KR |
|
Kaga Electronics Co Ltd
F:9V2
|
JP |
|
S
|
Systematix Securities Ltd
BSE:531432
|
IN |
|
P
|
PetIQ Inc
F:39L
|
US |
|
Bajaj Mobility AG
SIX:BMAG
|
AT |
|
A
|
Alternergy Holdings Corp
XPHS:ALTER
|
PH |
|
Crunchfish AB
F:1DA
|
SE |
|
Windtree Therapeutics Inc
NASDAQ:WINT
|
US |
Bankruptcy Probability
Aptamer Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptamer Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
59B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
464.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
238.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptamer Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptamer Sciences Inc has total debt of 98.3m KRW. This includes both short-term (0 KRW) and long-term (98.3m KRW) debt.
You can find a full breakdown on its Balance Sheet.
